AMSTERDAM, November 25 /PRNewswire-FirstCall/ -- Elsevier announced today that its flagship product Scopus, the world's largest abstract and citation database of peer-reviewed literature, will be nearly doubling its Arts & Humanities (A&H) titles. Access to the new journals will be available to Scopus users in April 2009. Currently the Scopus database contains 1,600 titles in A&H and related fields.
Many countries will be better represented as a result of these added titles and researchers will have enhanced access to international A&H content. Journal subjects include literature and literary theory (30% of new titles), general arts and humanities (22%), history (17%), visual/performing arts (16%), among others.
"Nearly doubling the Arts & Humanities titles will help make Scopus an even more comprehensive resource for our users," said Niels Weertman, Director Scopus and Scirus. "We are excited that Scopus is the most holistic cross-disciplinary database with the broadest coverage in Science, Technology, Medicine, Social Sciences and soon also in the Arts & Humanities.
"This broader coverage will be well received by the librarian and
research community," said Flora Grabowska, Science Librarian at
Covering the world's research literature, Scopus is the largest abstract and citation database of peer-reviewed literature and quality Web sources with smart tools to track analyze and visualize research. Scopus was designed and developed with over 500 users and librarians internationally. Its unique database contains abstracts and references from over 15,000 peer-reviewed journals from 4,000 publishers worldwide, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also directly integrates Web and patent searches. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool. For more information about Scopus please visit http://www.info.scopus.com.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult ( http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Contact: Malkie Bernheim/ Melanie Nadeau Padilla Speer Beardsley +1-212-752-8338 email@example.com/ firstname.lastname@example.org
Copyright©2008 PR Newswire.
All rights reserved